universal BCMA-targeting CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for universal BCMA-targeting CAR-T cells, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD [Phase 1]